IP Library Granted Patent US 7,897,374
Granted Patent B2
US 7,897,374 · App. 11/720,462 · Granted Mar 1, 2011

Human ABO blood group-binding lactobacilli

Assignee: Meiji Dairires Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,897,374
App. No.
11/720,462
Granted
Mar 1, 2011
Kind
B2
Abstract

Lactobacillus screening methods were carried out using surface plasmon resonance spectrums and human intestinal mucin and blood group antigens as probes. A trial to set selection criteria in the above-mentioned methods of screening for lactobacilli was made to adapt the methods to mass screening, and it was discovered that lactobacilli compatible with ABO blood groups can be screened by setting 100 RU as a criterion for judging bacterial binding under certain conditions. Using 238 lactobacillus strains, the above-mentioned screening methods and tests to judge their compatibility for the use of yogurt production were carried out, to at long last specifically discover bacillus strains compatible with blood groups A, B, and O.

Claims (32)

1. An intestine-binding Laclobacillus gasseri , having the ability to bind to a human A blood group antigen represented by

[GalNAcαl-3(Fucαl-2)Gal-],

wherein said lactobacillus is selected by the following criteria:

(i) blood group A antigen-recognizing ability obtained by BIACORE1000 measurement using a blood group A antigen probe is 2,000 RU or higher;

(ii) blood group B antigen-recognizing ability' obtained by BIACORE1000 measurement using a blood group B antigen probe is 100 RU or lower;

(iii) blood group H antigen-recognizing ability obtained by BIACORE1000 measurement using a blood group H antigen probe is 100 RU or lower;

(iv) the ratio of the A antigen-recognizing ability to the B antigen-recognizing ability is 70 or higher;

(v) the ratio of the A antigen-recognizing ability to the H antigen-recognizing ability is 100 or higher;

(vi) A-human colonic mucin (A-HCM)-recognizing ability obtained by BIACORE1000 measurement using HCM is 100 RU or higher; and

(vii) O-HCM-recognizing ability obtained by BIACORE1000 measurement using HCM is 100 RU or lower,

wherein the intestine-binding Lactobacillus gasseri is selected from the group consisting of Lactobacillus gasseri Accession No.: NITE BP-26 and Lactobacillus gasseri Accession No.: NITE BP-27.

2. An intestine-binding Lactobacillus gasseri , having the ability to bind to a human B blood group antigen represented by

[Galαl-3(Fucαl-2)Gal-],

wherein said lactobacillus is selected by the following criteria:

(i) blood group B antigen-recognizing ability obtained by BIACORE1000 measurement using a blood group B antigen probe is 2000 RU or higher;

(ii) blood group A antigen-recognizing ability obtained by BIACORE1000 measurement using a blood group A antigen probe is 100 RU or lower;

(iii) blood group H antigen-recognizing ability obtained by BIACORE1000 measurement using a blood group H antigen probe is 100 RU or lower;

(iv) the ratio of the B antigen-recognizing ability to the A antigen-recognizing ability is 50 or higher;

(v) the ratio of the B antigen-recognizing ability to the H antigen-recognizing ability is 20 or higher; and

(vi) B-HCM-recognizing ability obtained by BIACORE1000 measurement using HCM is higher than A-HCM- and H-HCM-recognizing abilities,

wherein the intestine-binding Lactobacillus gasseri is selected from the group consisting of Lactobacillus gasseri Accession No.: NITE BP-145 and Lactobacillus gasseri Accession No.: NITE BP-146.

3. An intestine-binding Lactobacillus gasseri , having the ability to bind to a human 0 blood group antigen represented by

[Fucαl-2Gal-],

wherein said lactobacillus is selected by the following criteria:

(i) blood group H antigen-recognizing ability obtained by BIACORE1000 measurement using a blood group H antigen probe is 700 RU or higher;

(ii) blood group A antigen-recognizing ability obtained by BIACORE1000 measurement using a blood group A antigen probe is 100 RU or lower;

(iii) blood group B antigen-recognizing ability obtained by BIACORE1000 measurement using a blood group B antigen probe is 100 RU or lower;

(iv) the ratio of the H antigen-recognizing ability to the A antigen-recognizing ability is 800 or higher;

(v) the ratio of the H antigen-recognizing ability to the B antigen-recognizing ability is 20 or higher;

(vi) O-HCM-recognizing ability obtained by BIACORE1000 measurement using HCM is 100 RU or higher; and

(vii) A-HCM-recognizing ability obtained by BIACORE1000 measurement using HCM is 1000 RU or lower,

wherein the intestine-binding Lactobacillus gasseri is selected from the group consisting of, Lactobacillus gasseri Accession No.: NITE BP-25 and Lactobacillus gasseri Accession No.: NITE BP-28.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2007
From: SAITO, TADAO; KAWAI, YASUSHI; UCHIDA, HIDEAKI; KIMURA, KATSUNORI; ISAWA, KAKUHEI; FURUICHI, KEISUKE
To: MEIJI DAIRIES CORPORATION
Reel/Frame 019760/0153 →
Priority Claims (2)
JP 2004-349135 · Dec 1, 2004 · national
JP PCT/JP2005/011043 · Jun 16, 2005 · national
Continuity (1)
Related Publication 20080160565A1 · Jul 3, 2008